(Q96021631)
Statements
Efficacy and Safety of Abicipar in Neovascular Age-Related Macular Degeneration: 52-Week Results of Phase 3 Randomized Controlled Study (English)
Derek Kunimoto
Young Hee Yoon
Charles C Wykoff
Andrew Chang
Rahul N Khurana
Raj K Maturi
Hansjürgen Agostini
Eric Souied
David R Chow
Andrew J Lotery
Masahito Ohji
Rubens Belfort
Xiao-Yan Li
Jenny Jiao
Grace Le
Werner Schmidt
Yehia Hashad
CEDAR and SEQUOIA Study Groups